Datopotamab Deruxtecan EGFR-Mutated NSCLC: Approved FDA 3 Mins Read Introduction to Datopotamab Deruxtecan EGFR-Mutated NSCLC On June 23, 2025, the FDA approved Datopotamab Deruxtecan EGFR-Mutated NSCLC treatment, known as…
